Beta Drugs Limited (NSE:BETA)

Market Cap	16.87B
Revenue (ttm)	3.86B
Net Income (ttm)	418.99M
Shares Out	10.09M
EPS (ttm)	53.63
PE Ratio	31.16
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,368
Average Volume	14,739
Open	1,657.40
Previous Close	1,671.40
Day's Range	1,609.20 - 1,661.40
52-Week Range	1,429.52 - 2,190.48
Beta	-0.31
RSI	38.58
Earnings Date	Nov 4, 2025

About Beta Drugs

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 399
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BETA

Financial Performance

In 2024, Beta Drugs's revenue was 3.62 billion, an increase of 22.54% compared to the previous year's 2.96 billion. Earnings were 424.19 million, an increase of 16.42%.